首页 | 本学科首页   官方微博 | 高级检索  
     

术前化疗联合干扰素、CD3AK细胞治疗对结肠癌患者早期免疫功能的影响及意义
引用本文:莫海山,周志伟,曾庆安,侯冰宗. 术前化疗联合干扰素、CD3AK细胞治疗对结肠癌患者早期免疫功能的影响及意义[J]. 肿瘤研究与临床, 2002, 14(6): 382-384
作者姓名:莫海山  周志伟  曾庆安  侯冰宗
作者单位:暨南大学医学院第三附属医院,广东 珠海 519000
摘    要:目的 :观察术前未化疗、术前化疗、术前化疗联合干扰素 CD3AK细胞治疗及术后结肠癌患者的近期机体免疫功能变化 ,找出满意的治疗方案。方法 :对 5 6例确诊为结肠癌又未发现有远处转移的患者随机分 A、B、C组。A组不行术前化疗 ,B组行术前化疗 ,C组行术前化疗并加用干扰素、CD3AK细胞 ,比较化疗前、化疗后 1周 ,术后 1、2、3周的机体免疫状态。结果 :术前化疗可严重抑制机体免疫功能 ,手术亦引起机体免疫功能下降。术前化疗加用干扰素、CD3AK细胞治疗可使机体免疫功能于化疗后明显提高 ,且于术后维持在高水平状态。结论 :新辅助化疗加用干扰素及 CD3AK细胞治疗是一种安全有效的抗肿瘤方法。

关 键 词:术前化疗  干扰素/CD3AK细胞  免疫功能
文章编号:1006-9801(2002)06-0382-02
修稿时间:2002-02-21

Effect and Clinical Significance of Early Immune Function of Patients with Colorectal Cancer of Pre-operative chemotherapy Combination With Interferon and CD3AK Cells
MO Hai shan,ZHOU Zhi wei,ZENG Qing an,et al.. Effect and Clinical Significance of Early Immune Function of Patients with Colorectal Cancer of Pre-operative chemotherapy Combination With Interferon and CD3AK Cells[J]. Cancer Research and Clinic, 2002, 14(6): 382-384
Authors:MO Hai shan  ZHOU Zhi wei  ZENG Qing an  et al.
Affiliation:MO Hai shan,ZHOU Zhi wei,ZENG Qing an,et al.The Third Auxiliary Hospital of Jinan University
Abstract:Objective:To observe the alteration of short term patients with colorectal cancer after pre operative without chemotherapy,pre operative chemotherapy combination with Interferon and CD 3AK Cells,so as to find the satisfactory treatment scheme.Methods:56 patients with histologically proven colorectal cancer and without distant metastases were randomized into three groups.Group A were without pre operative chemotherapy,group B were with pre operative chemotherapy,group C were with pre operative chemotherapy and combination with interferon and CD 3AK Cells.We compared three groups,body immune function a week after pre chemotherapy and post chemotherapy,and after the first,second,third post operative weeks.Results:Pre operative chemotherapy seriously inhibited the body immune function,operation also reduced body immune function obviously.The treatment of pre operative chemotherapy combination with interferon and CD 3AK Cells could enhance the body immune function obviously,and maintain immune function in high standard after operation.Conclusion:The treatment of neoadjuvant chemotherapy combination with interferon and CD 3AK Cells,is a safe and efficacious anti tumor way.
Keywords:Neoadjuvant chemotherapy  Interferon/CD 3AK Cells  Immune function
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号